<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 25, 1999
----------------
LIFE TECHNOLOGIES, INC.
--------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-14991 34-0431300
- ------------------------------ ----------- ------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
9800 Medical Center Drive, Rockville, Maryland 20850
- ---------------------------------------------- --------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (301) 610-8000
--------------
Not Applicable
--------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events.
On January 25, 1999, Life Technologies, Inc. issued the press release filed
herewith as Exhibit 99.
Item 7. Exhibits.
99 Press release, dated January 25, 1999.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LIFE TECHNOLOGIES, INC.
Date: January 26, 1999 By: /s/ Joseph C. Stokes, Jr.
------------------------------
Joseph C. Stokes, Jr.
Senior Vice President and
Chief Financial Officer
<PAGE>
EXHIBIT INDEX
99 Press release, dated January 25, 1999
<PAGE>
EXHIBIT 99
Contact: Joseph C. Stokes, Jr.
(301) 610-8000
LIFE TECHNOLOGIES' COMMON STOCK TO BE DELISTED
FROM NASDAQ STOCK MARKET EFFECTIVE
WITH CLOSE OF BUSINESS FEBRUARY 1, 1999
Rockville, Md., January 25, 1999 . . . Life Technologies, Inc. (Nasdaq: LTEK)
announced today that the Nasdaq Stock Market has notified the Company that,
effective with the close of business on February 1, 1999, the Company's Common
Stock will be delisted from the Nasdaq Stock Market, because of the Company's
inability to remain in compliance with certain maintenance standards required
for continued listing on the Nasdaq National Market, including the number of
shareholders and public float requirement. The Company fell out of compliance
with certain requirements as a result of the completed tender offer for the
Company's Common Stock by Dexter Corporation.
The Company remains a reporting company under the Securities and Exchange
Commission's rules. Additionally, the Company's Common Stock will be available
for immediate quotation on the OTC Bulletin Board effective with the start of
trading on February 2, 1999. The OTC Bulletin Board is operated by the National
Association of Securities Dealers as a forum for electronic trading and
quotation.
Life Technologies develops, manufactures and supplies more than 3,000 products
used principally in life science research and commercial manufacture of
genetically engineered products. The Company is a leading supplier of sera and
other cell growth media, as well as enzymes and other biological products
necessary for recombinant DNA procedures.
###
